Skip to main content

Seasonique FDA Approval History

FDA Approved: Yes (First approved May 25, 2006)
Brand name: Seasonique
Generic name: levonorgestrel and ethinyl estradiol
Dosage form: Extended-Cycle Oral Contraceptive Tablets
Company: Duramed Pharmaceuticals, Inc.
Treatment for: Birth Control

Seasonique (levonorgestrel/ethinyl estradiol) is an extended-cycle oral contraceptive regimen designed to reduce the number of withdrawal bleeding periods from monthly to four per year. Seasonique is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of birth control.

Development timeline for Seasonique

DateArticle
May 27, 2006Approval FDA Approves Duramed's Seasonique Extended-Cycle Oral Contraceptive
Mar 17, 2006Barr Confirms that Additional Clinical Data Is Not Required for Approval of Duramed's Seasonique Extended-Cycle Oral Contraceptive
Aug 18, 2005Barr Receives Approvable Letter for Duramed's Seasonique Extended-Cycle Oral Contraceptive
Dec 22, 2004Duramed's Seasonique NDA Accepted for Filing by FDA

See also

Seasonique (levonorgestrel and ethinyl estradiol) Consumer information

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer